1. A revised model of TRAIL‐R2 DISC assembly explains how FLIP(L) can inhibit or promote apoptosis. (3rd February 2020) Authors: Humphreys, Luke M; Fox, Jennifer P; Higgins, Catherine A; Majkut, Joanna; Sessler, Tamas; McLaughlin, Kirsty; McCann, Christopher; Roberts, Jamie Z; Crawford, Nyree T; McDade, Simon S; Scott, Christopher J; Harrison, Timothy; Longley, Daniel B Journal: EMBO reports Issue: Volume 21:Number 3(2020) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cytoplasmic FLIP(S) and nuclear FLIP(L) mediate resistance of castrate-resistant prostate cancer to apoptosis induced by IAP antagonists. Issue 11 (November 2018) Authors: McCann, Christopher; Crawford, Nyree; Majkut, Joanna; Holohan, Caitriona; Armstrong, Chris; Maxwell, Pamela; Ong, Chee; LaBonte, Melissa; McDade, Simon; Waugh, David; Longley, Daniel Journal: Cell death and disease Issue: Volume 9:Issue 11(2018) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Development of a protein signature to enable clinical positioning of IAP inhibitors in colorectal cancer. (27th March 2021) Authors: McCann, Christopher; Matveeva, Anna; McAllister, Katherine; Van Schaeybroeck, Sandra; Sessler, Tamas; Fichtner, Michael; Carberry, Steven; Rehm, Markus; Prehn, Jochen H.M.; Longley, Daniel B. Journal: FEBS journal Issue: Volume 288:Number 18(2021) Page Start: 5374 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗